112 related articles for article (PubMed ID: 25905517)
21. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
22. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
[TBL] [Abstract][Full Text] [Related]
23. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
[TBL] [Abstract][Full Text] [Related]
24. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
25. URINARY EXCRETION OF PLUTONIUM IN MAYAK WORKERS DURING AND AFTER CA-DTPA ADMINISTRATION.
Sokolova AB; Suslova KG; Miller SC
Radiat Prot Dosimetry; 2021 Dec; 197(3-4):154-162. PubMed ID: 34953463
[TBL] [Abstract][Full Text] [Related]
26. Four-decade follow-up of a plutonium-contaminated puncture wound treated with Ca-DTPA.
Avtandilashvili M; Tolmachev SY
J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34034246
[TBL] [Abstract][Full Text] [Related]
27. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats.
Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H
Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998
[TBL] [Abstract][Full Text] [Related]
28. Validation of a system of models for plutonium decorporation therapy.
Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
[TBL] [Abstract][Full Text] [Related]
29. Biokinetic model analysis with DTPA administration for a case of accidental inhalation of actinides in Japan.
Tani K; Ishigure N; Kim E; Tominaga T; Tatsuzaki H; Akashi M; Kurihara O
Radiat Prot Dosimetry; 2023 Oct; 199(15-16):2025-2029. PubMed ID: 37819312
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of 3,4,3-LIHOPO for enhancing the excretion of plutonium from rat after simulated wound contamination as a tributyl-n-phosphate complex.
Paquet F; Poncy JL; Metivier H; Grillon G; Fritsch P; Burgada R; Bailly T; Raymond KN; Durbin PW
Int J Radiat Biol; 1995 Dec; 68(6):663-8. PubMed ID: 8551109
[TBL] [Abstract][Full Text] [Related]
31. A BRIEF OVERVIEW OF COMPARTMENTAL MODELING FOR INTAKE OF PLUTONIUM VIA WOUNDS.
Poudel D; Klumpp JA; Waters TL; Bertelli L; Guilmette RA
Radiat Prot Dosimetry; 2018 Jan; 178(1):29-36. PubMed ID: 28591856
[TBL] [Abstract][Full Text] [Related]
32. Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge.
Dumit S; Bertelli L; Klumpp JA; Poudel D; Waters TL
Health Phys; 2020 Feb; 118(2):193-205. PubMed ID: 31833972
[TBL] [Abstract][Full Text] [Related]
33. The NCRP wound model: development and application.
Guilmette RA; Durbin PW; Toohey RE; Bertelli L
Radiat Prot Dosimetry; 2007; 127(1-4):103-7. PubMed ID: 17766262
[TBL] [Abstract][Full Text] [Related]
34. Internal contamination by actinides after wounding: a robust rodent model for assessment of local and distant actinide retention.
Griffiths NM; Wilk JC; Abram MC; Renault D; Chau Q; Helfer N; Guichet C; Van der Meeren A
Health Phys; 2012 Aug; 103(2):187-94. PubMed ID: 22951478
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the effects of inter-individual variation in the distribution of plutonium in skeleton and liver.
Klein W; Breustedt B
Radiat Prot Dosimetry; 2014; 158(3):276-84. PubMed ID: 24114619
[TBL] [Abstract][Full Text] [Related]
36. Chelation Modeling of a Plutonium-238 Inhalation Incident Treated with Delayed DTPA.
Dumit S; Miller G; Grémy O; Poudel D; Bertelli L; Klumpp JA
Radiat Res; 2023 Dec; 200(6):577-586. PubMed ID: 37956868
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the variability of biokinetic model parameters due to inter-individual variation.
Klein W; Breustedt B; Urban M
Health Phys; 2010 Oct; 99(4):577-80. PubMed ID: 20838102
[TBL] [Abstract][Full Text] [Related]
38. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
[TBL] [Abstract][Full Text] [Related]
39. Some Considerations for Chelation Treatment and Surgical Excision Following Incorporation of Plutonium in Wounds.
Poudel D; Bertelli L; Klumpp JA; Waters TL
Health Phys; 2018 Mar; 114(3):307-318. PubMed ID: 29360709
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ICRP 67 and Other Plutonium Systemic Model Predictions with the Biokinetic Data from Nonhuman Primates.
Poudel D; Krage ES; Brey RR; Guilmette RA
Health Phys; 2016 Apr; 110(4):361-9. PubMed ID: 26910028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
